InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
80.56
(
1.02%
)
Bitcoin
68,135.47
(
0.49%
)
Post# of 252714
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 25
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: masterlongevity post# 81558

Tuesday, 07/28/2009 1:51:08 PM

Tuesday, July 28, 2009 1:51:08 PM

Post# of 252714
would love to see another MS market share table. here is some of the requisite info from Teva's release.

The company said its global market share for Copaxone was 28 percent, ahead of Biogen's (BIIB.O) Avonex, which was 24 percent and 21 percent for Merck KGaA's (MRCG.DE) Rebif.
It had a 38 percent market share in the United States.

Do you think tysabri has gotten out of the single digits? It was last reported as having 9% market share in the US, but the market has grown.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up